| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.32 | 4e-11 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.3 | 1e-09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.25 | 4e-13 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |